The company currently holds 2.05
M in liabilities with Debt to Equity (D/E) ratio of 0.16, which may suggest the company is not taking enough advantage from borrowing. RA Medical Systems has a current ratio of 4.73, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist RA Medical until it has trouble settling it off, either with new capital or with free cash flow. So, RA Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like RA Medical Systems sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for RA Medical to invest in growth at high rates of return. When we think about RA Medical's use of debt, we should always consider it together with cash and equity.
On a scale of 0 to 100, RA Medical holds a
performance score of 2. The firm owns a Beta (Systematic Risk) of 0.2987, which implies not very significant fluctuations relative to the market. Let's try to break down what RA Medical's beta means in this case. As returns on the market increase, RA Medical returns are expected to increase less than the market. However, during the bear market, the loss on holding RA Medical will be expected to be smaller as well. Although it is vital to follow
RA Medical Systems existing
price patterns, it is good to be conservative about what you can do with the information regarding equity
price patterns. The way in which we are forecasting
future performance of any stock is to evaluate the business as a whole together with its past performance, including all
available fundamental and
technical indicators. By reviewing
RA Medical Systems technical indicators, you can at this moment evaluate if the expected return of 0.34% will be sustainable into the future. Please employ RA Medical Systems
sortino ratio,
semi variance, and the
relationship between the
information ratio and
value at risk to make a quick decision on whether RA Medical Systems current price history will revert.
RA Medical Systems Investment Alerts
RMED investment alerts and warnings help investors to get more proficient at understanding not only critical technical and fundamental signals but also the significant portfolio-centered indicators. These indicators include beta, alpha, and other risk-related measures that will help you in monitoring RA Medical Systems performance across your portfolios.Please check all
investment alerts for RMED
RA Medical Valuation Ratios as Compared to Competition
Our valuation model uses many indicators to compare RMED value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RA Medical competition to find
correlations between indicators driving the intrinsic value of RMED.
What is driving RA Medical Investor Appetite?
The latest surge in RA Medical Systems short term price appreciation created some momentum for shareholders as it was traded today as low as
4.5 and as high as
4.99 per share. The company directors and management have successfully maneuvered the entity at convenient times to take advantage of all market conditions in
November. The stock standard deviation of daily returns for 90 days investing horizon is currently 12.25. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the RA Medical Systems partners.
Margins Breakdown
RA Medical profit margins show the degree to which it makes money. Margin indicators are used not only by investors but also by creditors or RA Medical itself as indicators of financial health and management effectiveness. Please look more closely at the different varieties of RA Medical profit margins.
| Operating Margin | (68.21) |
| EBITDA Margin | (66.59) |
| Gross Margin | (27.07) |
| Profit Margin | (68.28) |
RA Medical Revenue Per Employee is rather stable at the moment. Further, RA Medical PPandE Turnover is rather stable at the moment.
Our take on today RA Medical surge
Latest kurtosis is at 2.72. RA Medical Systems is displaying above-average volatility over the selected time horizon. Investors should scrutinize RA Medical Systems independently to ensure intended market timing strategies are aligned with expectations about RA Medical volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure RA Medical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact RA Medical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.
Our Final Takeaway
Although some other entities under the medical devices industry are still a bit expensive, RA Medical may offer a potential longer-term growth to shareholders. The inconsistency in the assessment between current RA Medical valuation and our trade advice on RA Medical is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to RA Medical.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of RA Medical Systems. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
[email protected]